LBW242 is a Potent and Orally Active Proapoptotic IAP Inhibitor
Acute myelogenous leukemia (AML) is a hematologic malignancy. The characteristics include a block in cellular differentiation and aberrant growth of myeloid precursor cells. Approximately 30% of AML patients and a…